Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001116 |
---|---|
Receipt number | R000001351 |
Scientific Title | JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan |
Date of disclosure of the study information | 2008/04/09 |
Last modified on | 2021/09/27 04:59:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/04/09 12:48:55 | ||
2 | Update | 2011/05/09 17:12:23 | Last name of contact person Last name of contact person Institute |
|
3 | Update | 2013/05/07 14:30:51 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
4 | Update | 2013/05/07 14:38:28 | Recruitment status Publication of results URL related to results and publications Results Results Other related information Other related information |
|
5 | Update | 2013/11/05 17:48:31 | Email Institutions |
|
6 | Update | 2013/11/05 17:49:55 | Recruitment status |
|
7 | Update | 2013/11/05 17:52:20 | Other related information |
|
8 | Update | 2014/11/26 20:50:03 | Recruitment status Results Results |
|
9 | Update | 2015/10/11 12:18:12 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2021/02/12 14:27:29 | ||
11 | Update | 2021/06/04 21:36:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Name of secondary funder(s) Name of secondary funder(s) Organization Organization Address Address Tel |
|
12 | Update | 2021/09/27 04:47:34 | Recruitment status Date of IRB Anticipated trial start date |
|
13 | Update | 2021/09/27 04:59:13 | Publication of results Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |